• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对澳大利亚原住民依从性的系统评价:改善慢性病管理的契机。

A systematic review of adherence in Indigenous Australians: an opportunity to improve chronic condition management.

作者信息

de Dassel Jessica Langloh, Ralph Anna P, Cass Alan

机构信息

Charles Darwin University, Ellengowan Dr, Casuarina, Darwin, NT, 0810, Australia.

Menzies School of Health Research, Bld 58, Royal Darwin Hospital Campus, Rocklands Drive, Tiwi, Darwin, NT, 0811, Australia.

出版信息

BMC Health Serv Res. 2017 Dec 27;17(1):845. doi: 10.1186/s12913-017-2794-y.

DOI:10.1186/s12913-017-2794-y
PMID:29282117
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5745645/
Abstract

BACKGROUND

Indigenous Australians experience high rates of chronic conditions. It is often asserted Indigenous Australians have low adherence to medication; however there has not been a comprehensive examination of the evidence. This systematic literature review presents data from studies of Indigenous Australians on adherence rates and identifies supporting factors and impediments from the perspective of health professionals and patients.

METHODS

Search strategies were used to identify literature in electronic databases and websites. The following databases were searched: Scopus, Medline, CINAHL Plus, PsycINFO, Academic Search Premier, Cochrane Library, Trove, Indigenous Health infonet and Grey Lit.org . Articles in English, reporting original data on adherence to long-term, self-administered medicines in Australia's Indigenous populations were included. Data were extracted into a standard template and a quality assessment was undertaken.

RESULTS

Forty-seven articles met inclusion criteria. Varied study methodologies prevented the use of meta-analysis.

KEY FINDINGS

health professionals believe adherence is a significant problem for Indigenous Australians; however, adherence rates are rarely measured. Health professionals and patients often reported the same barriers and facilitators, providing a framework for improvement.

CONCLUSIONS

There is no evidence that medication adherence amongst Indigenous Australians is lower than for the general population. Nevertheless, the heavy burden of morbidity and mortality faced by Indigenous Australians with chronic conditions could be alleviated by enhancing medication adherence. Some evidence supports strategies to improve adherence, including the use of dose administration aids. This evidence should be used by clinicians when prescribing, and to implement and evaluate programs using standard measures to quantify adherence, to drive improvement in health outcomes.

摘要

背景

澳大利亚原住民慢性病发病率很高。人们常称澳大利亚原住民药物依从性低;然而,尚未对相关证据进行全面审查。这项系统性文献综述展示了有关澳大利亚原住民依从率研究的数据,并从医疗专业人员和患者的角度确定了支持因素和障碍。

方法

采用检索策略在电子数据库和网站中识别文献。检索了以下数据库:Scopus、Medline、CINAHL Plus、PsycINFO、学术搜索高级版、Cochrane图书馆、Trove、原住民健康信息网和Grey Lit.org。纳入了以英文撰写、报告澳大利亚原住民长期自我给药药物依从性原始数据的文章。数据被提取到一个标准模板中,并进行了质量评估。

结果

47篇文章符合纳入标准。研究方法各异,无法进行荟萃分析。

主要发现

医疗专业人员认为依从性是澳大利亚原住民的一个重大问题;然而,依从率很少被测量。医疗专业人员和患者经常报告相同的障碍和促进因素,这为改进提供了一个框架。

结论

没有证据表明澳大利亚原住民的药物依从性低于普通人群。然而,通过提高药物依从性,可以减轻患有慢性病的澳大利亚原住民面临的沉重发病和死亡负担。一些证据支持改善依从性的策略,包括使用剂量给药辅助工具。临床医生在开处方时应使用这些证据,并使用标准措施来量化依从性,以实施和评估项目,从而推动健康结果的改善。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce2/5745645/39b733f32559/12913_2017_2794_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce2/5745645/39b733f32559/12913_2017_2794_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce2/5745645/39b733f32559/12913_2017_2794_Fig1_HTML.jpg

相似文献

1
A systematic review of adherence in Indigenous Australians: an opportunity to improve chronic condition management.对澳大利亚原住民依从性的系统评价:改善慢性病管理的契机。
BMC Health Serv Res. 2017 Dec 27;17(1):845. doi: 10.1186/s12913-017-2794-y.
2
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
3
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
The measurement and monitoring of surgical adverse events.手术不良事件的测量与监测
Health Technol Assess. 2001;5(22):1-194. doi: 10.3310/hta5220.
6
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
9
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.
10
Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.不同吸入性糖皮质激素及其与长效β2受体激动剂联合使用治疗12岁及以上成人和儿童慢性哮喘比较效果的系统评价与经济学分析
Health Technol Assess. 2008 May;12(19):iii-iv, 1-360. doi: 10.3310/hta12190.

引用本文的文献

1
Guiding practice principles for clinicians who work with Indigenous people.与原住民合作的临床医生的指导实践原则。
Front Pediatr. 2025 Jun 17;13:1526753. doi: 10.3389/fped.2025.1526753. eCollection 2025.
2
Utilisation of endocrine therapy for cancer in Indigenous peoples: a systematic review and meta-analysis.原住民人群中癌症内分泌治疗的应用:系统评价和荟萃分析。
BMC Cancer. 2024 Jul 22;24(1):882. doi: 10.1186/s12885-024-12627-6.
3
Medication-related problems identified by community pharmacists: a descriptive case study of two Australian populations.

本文引用的文献

1
Improving delivery of secondary prophylaxis for rheumatic heart disease in remote Indigenous communities: study protocol for a stepped-wedge randomised trial.改善偏远原住民社区风湿性心脏病二级预防的实施:一项阶梯式楔形随机试验的研究方案
Trials. 2016 Jan 27;17:51. doi: 10.1186/s13063-016-1166-y.
2
The Effect of a Cardiovascular Polypill Strategy on Pill Burden.心血管复方药策略对用药负担的影响。
Cardiovasc Ther. 2015 Dec;33(6):347-52. doi: 10.1111/1755-5922.12151.
3
Characteristics of Indigenous adults with poorly controlled diabetes in north Queensland: implications for services.
社区药剂师识别出的与药物相关的问题:对澳大利亚两个人群的描述性案例研究。
J Pharm Policy Pract. 2023 Nov 2;16(1):133. doi: 10.1186/s40545-023-00637-x.
4
Māori, pharmacists, and medicines adherence - A mixed methods study exploring indigenous experiences of taking medicines 'as prescribed' and mechanisms of support.毛利人、药剂师与药物依从性——一项混合方法研究,探索原住民“按处方”服药的经历及支持机制。
Explor Res Clin Soc Pharm. 2022 Aug 28;7:100175. doi: 10.1016/j.rcsop.2022.100175. eCollection 2022 Sep.
5
Scoping review - What do we know about Aboriginal peoples' use of dose administration aids?范围综述 - 我们对原住民使用剂量给药辅助工具的了解有多少?
Health Promot J Austr. 2022 Oct;33 Suppl 1(Suppl 1):117-127. doi: 10.1002/hpja.577. Epub 2022 Mar 17.
6
Diabetes Capabilities for the Healthcare Workforce Identified via a 3-Staged Modified Delphi Technique.采用三阶段改良德尔菲技术确定医疗保健人员的糖尿病能力。
Int J Environ Res Public Health. 2022 Jan 17;19(2):1012. doi: 10.3390/ijerph19021012.
7
How Many Doses Make a Difference? An Analysis of Secondary Prevention of Rheumatic Fever and Rheumatic Heart Disease.多少剂量有差异?风湿热和风湿性心脏病二级预防的分析。
J Am Heart Assoc. 2018 Dec 18;7(24):e010223. doi: 10.1161/JAHA.118.010223.
北昆士兰地区控制不佳的糖尿病原住民成年人的特征:对服务的启示。
BMC Public Health. 2015 Apr 3;15:325. doi: 10.1186/s12889-015-1660-2.
4
Understanding if, how and why non-adherent decisions are made in an Australian community sample: a key to sustaining medication adherence in chronic disease?了解澳大利亚社区样本中不依从决策的情况、方式及原因:这是维持慢性病药物依从性的关键吗?
Res Social Adm Pharm. 2015 Mar-Apr;11(2):154-62. doi: 10.1016/j.sapharm.2014.06.006. Epub 2014 Jul 20.
5
Chronic conditions, financial burden and pharmaceutical pricing: insights from Australian consumers.慢性病、经济负担与药品定价:来自澳大利亚消费者的见解
Aust Health Rev. 2014 Nov;38(5):589-95. doi: 10.1071/AH13190.
6
Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.固定剂量联合治疗对心血管疾病高危患者依从性和危险因素控制的影响:初级保健中的随机对照试验。
BMJ. 2014 May 27;348:g3318. doi: 10.1136/bmj.g3318.
7
A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk.一项基于复方药丸策略改善高危心血管疾病人群接受既定预防治疗的实用随机试验。
Eur J Prev Cardiol. 2015 Jul;22(7):920-30. doi: 10.1177/2047487314530382. Epub 2014 Mar 27.
8
Identifying barriers and improving communication between cancer service providers and Aboriginal patients and their families: the perspective of service providers.确定癌症服务提供者与原住民患者及其家属之间的沟通障碍并加以改善:服务提供者的观点。
BMC Health Serv Res. 2013 Nov 4;13:460. doi: 10.1186/1472-6963-13-460.
9
They've given me that many tablets, I'm bushed. I don't know where I'm going: Aboriginal and Torres Strait Islander peoples' experiences with medicines.他们给了我那么多药片,我累坏了。我不知道自己要走向何方:原住民和托雷斯海峡岛民的用药经历。
Aust J Rural Health. 2013 Aug;21(4):216-9. doi: 10.1111/ajr.12053.
10
A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia.澳大利亚一项针对经济激励措施提高注射吸毒者乙型肝炎疫苗接种完成率的随机对照试验。
Prev Med. 2013 Oct;57(4):297-303. doi: 10.1016/j.ypmed.2013.04.013. Epub 2013 Apr 29.